Lunate Holding RSC Ltd
CIK
2009522
Location
AL MARYAH ISLAND, ABU DHABI, C0
Portfolio Value
Small
$210,946,303
Diversification
Highly concentrated
Filing Date
Dec 31, 2024
Global Rank
#4,917
/ 8,174
· as of Dec 2024
Top Industry
Biotechnology
56.2%
3Y Alpha vs SPY
-35.6%
Period ended 1 year ago
Filed Feb 14, 2025 · 1y
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
4 tracked positions · as of Dec 31, 2024Top Position
45.5%
of portfolio value
Top 5
100.0%
of portfolio value
Top 10
100.0%
of portfolio value
HHI
3,201
Highly concentrated
Sector Breakdown
As of Dec 31, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 56.2% | $118,577,703 |
| Consumer Cyclical | 27.1% | $57,226,600 |
| Real Estate | 16.7% | $35,142,000 |
4 tracked positions ·
$210,946,303 total
· filing declares
4 positions · $210,946,304
· as of Dec 31, 2024
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
First | 2,196,200 | $96,061,788 | 45.54% | |
| BIRK |
Birkenstock Holding plc
Consumer Cyclical
|
First | 1,010,000 | $57,226,600 | 27.13% | |
| LINE |
Lineage, Inc.
Real Estate
|
First | 600,000 | $35,142,000 | 16.66% | |
| NMRA |
Neumora Therapeutics, Inc.
Healthcare
|
First | 2,124,143 | $22,515,915 | 10.67% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.